DrCarney.com Blog
Health - Food - Science - Community
1 minute reading time
(100 words)
Trajectories of alcohol consumption during life and the risk of developing breast cancer
Regular drinking of alcoholic beverages may fuel the development of breast cancer in women.
The purpose of this study was to determine the risk of breast cancer in women based on the level of alcohol consumption. Researchers compared the alcohol drinking habits of 1,278 women diagnosed with breast cancer with another group 1,278 females without the disease.
Researchers noted that the greater the amount of alcohol consumed by a woman during her lifetime, the higher her chances of developing breast cancer. The data from this study support the hypothesis that alcohol intake may make a woman highly susceptible to breast cancer.
Research Summary Information
-
2021
-
Carolina Donat-Vargas, Ángel Guerrero-Zotano, Ana Casas, José Manuel Baena-Cañada, Virginia Lope, Silvia Antolín, José Ángel Garcia-Saénz, Begoña Bermejo, Montserrat Muñoz, Manuel Ramos, Ana de Juan, Carlos Jara Sánchez, Pedro Sánchez-Rovira, Antonio Antón, Joan Brunet, Joaquín Gavilá, Javier Salvador, Esperanza Arriola Arellano, Susana Bezares, Nerea Fernández de Larrea-Baz, Beatriz Pérez-Gómez, Miguel Martín, Marina Pollán
-
IMDEA-Food Institute, CEI UAM+CSIC, Madrid, Spain. Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid-IdiPaz, CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain. Unit of Cardiovascular and Nutritional Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden. Medical Oncology Unit, Instituto Valenciano de Oncología, Valencia, Spain. Medical Oncology Unit, Hospital Virgen del Rocío, Sevilla, Spain. Medical Oncology Unit, Hospital Puerta del Mar, Cádiz, Spain. Instituto de Investigación en Biomedicina de Cádiz (INiBICA), Cádiz, Spain. National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain.Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain. Medical Oncology Unit, Complejo Hospitalario Universitario, A Coruña, Spain. Medical Oncology Unit, Hospital Clínico Universitario San Carlos, Madrid, Spain. Medical Oncology Unit, Hospital Clínico, Valencia, Spain. Medical Oncology Unit, Hospital Clinic i Provincial, Barcelona, Spain. Translational Genomics and Targeted Therapeutics, Institut d'Investigacions Biomèdiques Pi i Sunyer-IDIBAPS, Barcelona, Spain. Medical Oncology Unit, Centro Oncológico de Galicia, A Coruña, Spain. Medical Oncology Unit, Hospital Marqués de Valdecilla, Santander, Spain. Medical Oncology Unit/Departamento Especialidades Médicas, Hospital Universitario Fundación Alcorcón/Universidad Rey Juan Carlos, Madrid, Spain. Medical Oncology Unit, Hospital Universitario de Jaén, Jaén, España. Medical Oncology Unit, Hospital Universitario Miguel Servet, Zaragoza, España. Medical Oncology Department, Institut Català d'Oncologia, IDIBGi, Girona, Spain. Medical Sciences Department, Universitat de Girona, Girona, Spain. GEICAM Spanish Breast Cancer Research Group, Madrid, Spain. Medical Oncology Unit, Instituto de Investigación Sanitaria Gregorio Marañón/Universidad Complutense, Madrid, Spain. Centro de Investigación Biomédica en Red de Oncología, CIBERONC-ISCIII, Madrid, Spain. Department of Preventive Medicine and Public Health, School of Medicine, Universidad Autónoma de Madrid-IdiPaz, CIBERESP (CIBER of Epidemiology and Public Health), Madrid, Spain. mpollan@isciii.es. National Center for Epidemiology, Carlos III Institute of Health, Madrid, Spain. mpollan@isciii.es. Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Institute of Health Carlos III, Madrid, Spain. mpollan@isciii.es.
-
Yes, Free full text of study was found:
Stay Informed
When you subscribe to the blog, we will send you an e-mail when there are new updates on the site so you wouldn't miss them.
About the author
